Prenetics sells ACT Genomics stake for $71.78 million to strengthen Bitcoin financial strategy

Odaily News Prenetics, a NASDAQ-listed company, announced that it has entered into a definitive agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Corporation for approximately $71.78 million. The divestiture of ACT Genomics significantly strengthens Prenetics' financial foundation with estimated cash reserves of approximately $86 million and estimated cash and short-term assets of $117 million. The Company maintains a debt-free balance sheet with zero liabilities, allowing it to explore alternative financial management options, including digital asset adoption and Bitcoin financial strategies. (Globenewswire)